当前位置:
X-MOL 学术
›
ACS Med. Chem. Lett.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to "Accelerated Discovery of Novel Ponatinib Analogs with Improved Properties for the Treatment of Parkinson's Disease".
ACS Medicinal Chemistry Letters ( IF 4.2 ) Pub Date : 2020-06-24 , DOI: 10.1021/acsmedchemlett.0c00336 Thomas M. Kaiser , Zackery W. Dentmon , Christopher E. Dalloul , Savita K. Sharma , Dennis C. Liotta
ACS Medicinal Chemistry Letters ( IF 4.2 ) Pub Date : 2020-06-24 , DOI: 10.1021/acsmedchemlett.0c00336 Thomas M. Kaiser , Zackery W. Dentmon , Christopher E. Dalloul , Savita K. Sharma , Dennis C. Liotta
The columns in Table 2 in the original manuscript listing the kinase data for compounds 4 and 5 were switched. This revision corrects that error. This article has not yet been cited by other publications.
中文翻译:
对“加快发现具有改善性能的帕金森氏病的新型波纳替尼类似物的发现”的更正。
原始手稿中表2中列出了化合物4和5激酶数据的列已切换。此修订版纠正了该错误。本文尚未被其他出版物引用。
更新日期:2020-07-09
中文翻译:
对“加快发现具有改善性能的帕金森氏病的新型波纳替尼类似物的发现”的更正。
原始手稿中表2中列出了化合物4和5激酶数据的列已切换。此修订版纠正了该错误。本文尚未被其他出版物引用。